摘要 |
<p>The present invention relates to the treatment of osteoarthritis and pain using IL-1α and IL-1β binding proteins, including anti-IL-1α and IL-1β antibodies and engineered multivalent and multispecific IL-1α and IL-1β binding proteins.</p> |